Clinical Trial Update: Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemotherapy with or without a GnRH agonist in premenopausal patients with triple-negative early breast cancer. Recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Triple Negative Breast Cancer, Premenopausal Breast Cancer | Phase 2 | Status: RECRUITING